Chongqing Zhifei Biological Products Co., Ltd. Share Price
Equities
300122
CNE100000V20
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.00 CNY | +0.76% |
|
+1.78% | -23.95% |
| Capitalization | 47.88B 6.67B 5.7B 5.31B 4.91B 9.14B 572B 10.21B 63.53B 24.17B 267B 25.01B 24.49B 977B | P/E ratio 2025 * |
26.9x | P/E ratio 2026 * | 12.8x |
|---|---|---|---|---|---|
| Enterprise value | 41.32B 5.76B 4.92B 4.58B 4.24B 7.89B 493B 8.82B 54.83B 20.86B 230B 21.59B 21.14B 843B | EV / Sales 2025 * |
2.05x | EV / Sales 2026 * | 1.35x |
| Free-Float |
14.76% | Yield 2025 * |
0.68% | Yield 2026 * | 0.9% |
More valuation ratios
* Estimated data
More news
More news
| 1 day | +0.76% | ||
| 1 week | +1.78% | ||
| Current month | +2.09% | ||
| 1 month | +2.56% | ||
| 3 months | -11.27% | ||
| 6 months | -20.54% | ||
| Current year | -23.95% |
| 1 week | 19.36 |  | 20.29 |
| 1 month | 18.81 | | 20.66 |
| Current year | 18.7 | | 27.8 |
| 1 year | 18.7 | | 40.43 |
| 3 years | 18.7 | | 77.77 |
| 5 years | 18.7 | | 154.13 |
| 10 years | 5.35 | | 154.13 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhen Jing Li
DFI | Director of Finance/CFO | 43 | 18/08/2015 |
Ren Sheng Jiang
PSD | President | 72 | 16/08/2009 |
Jie Xun
PRN | Corporate Officer/Principal | 36 | 31/12/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Ren Sheng Jiang
CHM | Chairman | 72 | 16/08/2009 |
Ling Feng Jiang
BRD | Director/Board Member | 45 | 09/08/2018 |
Zhen Jing Li
BRD | Director/Board Member | 43 | 09/04/2018 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.76% | +1.78% | -23.25% | -73.25% | 6.62B | ||
| -0.86% | +0.73% | -19.10% | -16.14% | 77.69B | ||
| +0.88% | +3.30% | -47.49% | -11.10% | 57.88B | ||
| +0.49% | +1.80% | +28.54% | +24.30% | 52.56B | ||
| +0.12% | +2.07% | +19.26% | +98.16% | 37.85B | ||
| -1.07% | +2.27% | -41.68% | -39.20% | 19.7B | ||
| -0.12% | +4.91% | +117.59% | +123.51% | 17.93B | ||
| +1.07% | +13.69% | +55.41% | +695.31% | 16.32B | ||
| -0.04% | -.--% | +84.28% | +129.06% | 14.02B | ||
| +1.55% | -0.01% | +18.14% | -14.61% | 13.1B | ||
| Average | +0.27% | +1.97% | +19.17% | +91.60% | 31.37B | |
| Weighted average by Cap. | +0.10% | +1.89% | +4.64% | +54.26% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 20.19B 2.81B 2.4B 2.24B 2.07B 3.85B 241B 4.31B 26.79B 10.19B 113B 10.55B 10.33B 412B | 27.93B 3.89B 3.32B 3.1B 2.86B 5.33B 333B 5.96B 37.07B 14.1B 156B 14.59B 14.29B 570B |
| Net income | 1.6B 223M 190M 178M 164M 306M 19.12B 342M 2.12B 808M 8.93B 836M 819M 32.68B | 3.77B 524M 448M 417M 386M 719M 44.95B 803M 5B 1.9B 21B 1.97B 1.93B 76.84B |
| Net Debt | -6.56B -913M -780M -727M -672M -1.25B -78.28B -1.4B -8.7B -3.31B -36.57B -3.42B -3.35B -134B | -10.07B -1.4B -1.2B -1.12B -1.03B -1.92B -120B -2.15B -13.36B -5.08B -56.15B -5.26B -5.15B -205B |
More financial data
* Estimated data
Employees
7,220
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/07/25 | 20.00 ¥ | +0.76% | 31,608,030 |
| 08/07/25 | 19.85 ¥ | +2.11% | 32,710,410 |
| 07/07/25 | 19.44 ¥ | -0.82% | 15,863,630 |
| 04/07/25 | 19.60 ¥ | -1.21% | 22,810,300 |
| 03/07/25 | 19.84 ¥ | +0.40% | 26,393,890 |
End-of-day quote Shenzhen S.E., July 08, 2025
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
20.00CNY
Average target price
29.73CNY
Spread / Average Target
+48.67%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300122 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition